Zero tolerance for disease activity on treatment is near (but not yet)

 

REPORT FROM THE EUROPEAN CHARCOT FOUNDATION ANNUAL MEETING – BAVENO, ITALY, NOVEMBER 28-30, 2013 – Recent studies have attempted to identify baseline disease characteristics that would predict response to a given treatment, but no factors have been determined thus far. However, markers of disease activity during treatment can be useful for identifying treatment failure.

It takes 30 seconds

Recommend to a Colleague

Related Posts

Go back to home page